News & Events > News > Former New York Geno...

Former New York Genome Center Postdoc, Mat Legut, PhD, Included in New York Business Journal Article

New York, NY  ·  February 24, 2023
Andrew Burton via Getty Images

Mat Legut, PhD, was recently interviewed for a New York Business Journal article on Hudson Square’s emergence as a life-sciences hub.

Dr. Mat Legut, Former NYGC Postdoc

Mat was previously a Hope Funds for Cancer Research Fellow in the lab of Dr. Neville Sanjana at the New York Genome Center (NYGC) and NYU, where he developed high-throughput approaches to discover novel regulators of the immune response.

Dr. Legut is now the CEO and CSO of OverT Bio, an NYGC spinout company.  OverT Bio is a venture-backed TechBio company building next-generation cell therapies to identify and develop novel genetic modifications that will enable immune cells to overcome barriers created by tumors, leading to effective and durable immunotherapies for hard-to-treat cancers.

Access the full article here.


Back to All News Next News Post
Decorative image color fade left Decorative image color fade right Decorative image color fade